fbpx

Tag: Alzheimer’s Disease

September 9, 2019

Despite current treatment options, there is still no cure for Alzheimer’s. Current treatment options only temporarily slow the symptoms of dementia and keep them from worsening. Finding more effective options and even a cure comes down to testing new potential treatments via clinical trials.

What is Alzheimer’s?

Alzheimer’s Disease (AD) is the most common form of dementia and is not a normal part of aging. It causes memory loss and other cognitive problems that gradually worsen over time. Eventually, every aspect of a person’s daily life is impacted when they have AD. Early stages impact memory, while later stages come with mood changes and behavioral changes. It can even affect a person’s ability to walk, speak, and swallow.

Although the majority of those affected with AD are over 65, approximately 200,000 Americans under 65 have early-onset Alzheimer’s. On average, a person lives 4-8 years after diagnosis, and up to 20 years depending on various factors. It is the 6th leading cause of death in the U.S.

Don’t Just Hope, Help.

More participants are needed in clinical trials to help evaluate potential treatment options and to find a cure. Through the clinical trial process, more effective treatments and prevention opportunities can be found.

Beta-amyloid protein and biomarker studies that explore what causes AD have provided cutting-edge treatments and led to better medical care. However, none of these advancements are possible without volunteers. Here are some of the benefits of participating in a clinical trial:

  • You can help future generations
  • Participation may help you get more involved in your healthcare
  • You or your loved one may have access to new treatments not available to the public

Volunteers that have a family history of AD, dementia and even those with no history are all needed. The data that is gathered from your results are used to determine whether a new medication or therapy is safe and effective.

ActivMed Practices & Research, like many other research facilities, has joined the fight to cure Alzheimer’s by conducting clinical trials. If you or someone you love is diagnosed with Alzheimer’s and are interested in hearing more about our study opportunities, click HERE.

 

References:

https://www.alz.org/alzheimers-dementia/what-is-alzheimers

Share!
error
March 27, 2019

Could people’s eyes and ears help fix the damage Alzheimer’s disease does to the brain? Just by looking at flashing light and listening to flickering sound?

Click here to read this article posted in the New York Times March 14th, describing an exciting research study being conducted here at ActivMed, as well as many other research sites.

“Light and sound combined magnified the brain effects and extended them to the prefrontal cortex, a key area for planning and executing tasks.”

 

To learn more about this study please click below for our Methuen, MA office.

Join a Trial in Methuen, MA

Or click below for our Portsmouth, NH office

Join a Trial in Portsmouth, NH

 

Share!
error

Learn about memory loss, what’s normal and what may be a concern. Join us for an afternoon of Cookies, Coffee, Cocoa & Tea Tuesday, November 13th 2-4 PM You are cordially invited to visit our new Learning Center in our research facility. Short Presentation by: Robert Portney, MD & Allison Castonguay, APRN, FNP-BC 421 Merrimack Street, Suite 204, Methuen MA, 01844 RSVP: 978-655-7155

Share!
error
November 7, 2018
National Alzheimer

Impacting the lives of over five million people in the U.S. alone, Alzheimer’s Disease is one of the leading diagnoses in seniors over the age of 65. Nearly every household has felt the effect of this incurable condition, whether personal or in witness to the toll it has had on national celebrities, such as activist Rosa Parks or actor James Stuart.

National Alzheimer’s Disease Awareness Month celebrates the families and fighters of Alzheimer’s, promotes a hopeful future and search for a cure.

National Alzheimer's Disease Awareness

When was National Alzheimer’s Disease Awareness Month founded?

Preceding his diagnosis in 1994, President Ronald Reagan signed Proclamation 5110 in November 1983, establishing that month as National Alzheimer’s Disease Awareness Month to recognize the condition as a serious concern to the growing U.S. population. Since that time, this awareness month has been utilized to encourage research, community support and education of memory loss and Alzheimer’s symptoms.

How is Alzheimer’s Disease diagnosed?

If someone begins to experience or display significant memory loss symptoms, physician may use several methods to determine whether or not that individual has some form of dementia.

First, a physician may conduct an overall health and memory screening. A memory screening is a series of tasks and questions used to test memory, cognition, language skills and other intellectual functions. The doctor can use this information over a span of time to measure cognition and gauge mental condition.

Standard medical tests, including blood and urine testing, in addition to brain scans, such as MRI or CAT scans, can also be used to rule out other symptoms, such as stroke or the presence of a tumor.

What are the symptoms of Alzheimer’s Disease?

According to Mayo Clinic, there are five primary symptoms of Alzheimer’s Disease:

  • Memory loss or lapse
  • Difficulty with concentration
  • Difficulty with decision making and reasoning
  • Inability to perform routine tasks (such as cooking or getting dressed)
  • Changes in personality (including mood swings, social withdrawals, apathy and distrust in others)

How can I participate in National Alzheimer’s Disease Awareness Month?

Across the nation, there are many opportunities to be involved and raise awareness for Alzheimer’s Disease. Awareness walks, 5K races, charity events and volunteerism are just a few options on how you can become involved in your community. Physicians at ActivMed also offer free memory screenings by appointment, at no cost to you nor is insurance needed.

If you or someone you know has experienced memory loss, or has been diagnosed with Alzheimer’s disease, you may also be eligible to participate in clinical research! Qualified candidates will receive study-related care and medication at no cost, as well as receive compensation for travel. To learn more on how you can be involved, CLICK HERE.

Share!
error
October 30, 2018
memory loss

Most people experience more moments than they can recall. From our first steps to dinner last night, we often have difficulty remembering all of the details from each day. Fortunately, the mind subconsciously stores many of these special moments as memories to be triggered by or associated with specific environmental factors for later recollection.

With each unique memory being more precious than the last, memory loss can be a frustrating experience to endure; however, cutting-edge research may provide new treatment opportunities and hope for patients diagnosed with mild cognitive impairment.

memory loss

First, what is mild cognitive impairment?

According to Mayo Clinic, memory loss, or mild cognitive impairment, is the stage between expected cognitive decline and aging, and the more serious decline of dementia. This condition affects over 20% of the U.S. population over the age of 65, and can often be the early onset of other cognitive diseases, such Alzheimer’s disease.

How is memory loss treated?

Since Dr. Alois Alzheimer first linked microscopic brain formations to memory loss in 1906, scientists have been searching for new, more effective ways to treat patients suffering from cognitive impairment. Due to the complicated nature of the condition, it wasn’t until the mid-1990’s that treatment options first emerged, with the FDA approval of a drug called tacrine (Cognex).

Based on information from the Alzheimer’s Association, there are two primary types of medication assigned to treat cognitive impairment symptoms: cholinesterase inhibitors and memantine. Cholinesterase inhibitors are prescribed to treat early to moderate stage memory loss or Alzheimer’s disease by helping prevent the breakdown of chemicals messengers used to stimulate learning and memory, while memantine is used to treat severe Alzheimer’s disease to improve daily function and information processing.

memory loss

Is there a cure for memory loss and dementia?

Unfortunately, there is no known cure for these conditions. Physicians at ActivMed are looking to change this reality by continually seeking new treatment options for patients diagnosed with mild cognitive impairment. If you or someone you know has experienced memory loss, or has been diagnosed with Alzheimer’s disease, you may be eligible to participate in clinical research! Qualified candidates who decide to participate will receive study-related visits and lab work at no cost, as well as receive compensation for travel. To learn more on how you can be involved, CLICK HERE.

Share!
error
×
Beverly, MA

×
Methuen, MA

×
Portsmouth, NH

×
Lawrence, MA

×